Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
Author:
Open Access
- 14 November 2012
- journal article
- Published by Wiley in ISRN Obstetrics and Gynecology
- Vol. 2012, 1-8
Abstract
Background. The aim was to evaluate predictive and prognostic factors in a large consecutive series of endometrial carcinomas and to discuss pre- and postoperative risk groups based on these factors. Material and Methods. In a consecutive series of 4,543 endometrial carcinomas predictive and prognostic factors were analyzed with regard to recurrence rate and survival. The patients were treated with primary surgery and adjuvant radiotherapy. Two preoperative and three postoperative risk groups were defined. DNA ploidy was included in the definitions. Eight predictive or prognostic factors were used in multivariate analyses. Results. The overall recurrence rate of the complete series was 11.4%. Median time to relapse was 19.7 months. In a multivariate logistic regression analysis, FIGO grade, myometrial infiltration, and DNA ploidy were independent and statistically predictive factors with regard to recurrence rate. The 5-year overall survival rate was 73%. Tumor stage was the single most important factor with FIGO grade on the second place. DNA ploidy was also a significant prognostic factor. In the preoperative risk group definitions three factors were used: histology, FIGO grade, and DNA ploidy. Conclusions. DNA ploidy was an important and significant predictive and prognostic factor and should be used both in preoperative and postoperative risk group definitions.Keywords
This publication has 24 references indexed in Scilit:
- Prognostic significance of DNA ploidy in stage I endometrial cancerGynecologic Oncology, 2011
- Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studiesEuropean Journal of Cancer, 2010
- Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial CancerInternational Journal of Gynecological Cancer, 2009
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysisThe Lancet, 2009
- Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancerGynecologic Oncology, 2005
- TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancerInternational Journal of Gynecological Cancer, 2002
- Prognostic importance of the nuclear proteins p53 and Rb in conjunction with DNA, nuclear morphometry and grading in endometrial carcinomaInternational Journal of Gynecological Cancer, 1997
- Carcinoma of the Endometrium: Do the Nuclear Grade and DNA Ploidy Provide More Prognostic Information than Do the FIGO and WHO Classifications?International Journal of Gynecological Pathology, 1996
- Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk casesInternational Journal of Gynecological Cancer, 1996
- Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973‐87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vaginaSeminars in Surgical Oncology, 1994